Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T18:19:03.248Z.
Calculation as of: 2026-10-06T18:19:03.248Z.
Quote observation: 2026-10-06T18:12:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e70a31ba84f000c4f33ebb31a0a06a86ed13fe2ad2db34235caa158b2a7ba390
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2005-11-10.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.84M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.17M
EV/EBITDA Ratio
N/A
TTM Avg
10388992794.84x
3Y Avg
12435877641.77x
5Y Avg
12435877641.77x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | $1.86M | N/A | N/A | N/A | N/A |
| Tenon Medical, Inc. (TNON)vs › | $1.85M | N/A | N/A | N/A | N/A |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.84M | N/A | N/A | N/A | N/A |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.88M | N/A | N/A | N/A | N/A |
| Beyond Air, Inc. (XAIR)vs › | $1.89M | N/A | N/A | N/A | N/A |
| Autonomix Medical, Inc. (AMIX)vs › | $1.93M | N/A | N/A | N/A | N/A |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | N/A | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.17M | N/A | 10388992794.84x | 12435877641.77x | 12435877641.77x |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.18M | N/A | N/A | N/A | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.48M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2005-11-10 | 146.28x |
| 2005-11-09 | 146.28x |
| 2005-11-08 | 585.92x |
| 2005-11-07 | 585.92x |
| 2005-11-04 | 585.92x |
| 2005-11-03 | 585.92x |
| 2005-11-02 | 585.92x |
| 2005-11-01 | 585.92x |
| 2005-10-31 | 585.92x |
| 2005-10-28 | 585.92x |
| 2005-10-27 | 585.92x |
| 2005-10-26 | 585.92x |
| 2005-10-25 | 585.92x |
| 2005-10-24 | 585.92x |
| 2005-10-21 | 585.92x |
| 2005-10-20 | 585.92x |
| 2005-10-19 | 585.92x |
| 2005-10-18 | 585.92x |
| 2005-10-17 | 585.92x |
| 2005-10-14 | 585.92x |
| 2005-10-13 | 585.92x |
| 2005-10-12 | 585.92x |
| 2005-10-11 | 585.92x |
| 2005-10-10 | 585.92x |
| 2005-10-07 | 585.92x |
| 2005-10-06 | 585.92x |
| 2005-10-05 | 585.92x |
| 2005-10-04 | 585.92x |
| 2005-10-03 | 585.92x |
| 2005-09-30 | 585.92x |
| 2005-09-29 | 585.92x |
| 2005-09-28 | 585.92x |
| 2005-09-27 | 585.92x |
| 2005-09-26 | 585.92x |
| 2005-09-23 | 585.92x |
| 2005-09-22 | 585.92x |
| 2005-09-21 | 585.92x |
| 2005-09-20 | 585.92x |
| 2005-09-19 | 585.92x |
| 2005-09-16 | 585.92x |
| 2005-09-15 | 585.92x |
| 2005-09-14 | 585.92x |
| 2005-09-13 | 585.92x |
| 2005-09-12 | 585.92x |
| 2005-09-09 | 585.92x |
| 2005-09-08 | 585.92x |
| 2005-09-07 | 585.92x |
| 2005-09-06 | 585.92x |
| 2005-09-02 | 585.92x |
| 2005-09-01 | 585.92x |
| 2005-08-31 | 585.92x |
| 2005-08-30 | 585.92x |
| 2005-08-29 | 585.92x |
| 2005-08-26 | 585.92x |
| 2005-08-25 | 585.92x |
| 2005-08-24 | 585.92x |
